Company Filing History:
Years Active: 2014-2020
Title: Innovations and Contributions of Nigel Peter Minton
Introduction
Nigel Peter Minton is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of biotechnology, particularly in the development of DNA molecules and cancer treatment methods. With a total of four patents to his name, Minton's work has the potential to impact various scientific and medical applications.
Latest Patents
Minton's latest patents include a DNA molecule that comprises a modified Group II intron. This DNA molecule does not express the intron-encoded reverse transcriptase but contains a modified selectable marker gene in reverse orientation. The marker gene comprises a Group I intron that causes expression in a bacterial cell of the class Clostridia. Additionally, the DNA molecule allows for the insertion of the RNA transcript of the Group II intron into the chromosome of a bacterial cell of the class Clostridia. This innovation is useful for making mutations. Another significant patent involves a method of treatment for cancer. This method includes administering a prodrug to a subject colonized with an obligate anaerobic microorganism capable of expressing a polypeptide with nitroreductase activity. This polypeptide preferentially reduces CB1954 to a 4-hydroxylamine derivative, which is crucial for treating solid tumors.
Career Highlights
Throughout his career, Minton has worked with esteemed institutions such as the University of Nottingham and Morvus Technology Limited. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Minton has collaborated with notable individuals in his field, including John Timothy Heap and Ying Zhang. These collaborations have likely enriched his research and led to innovative breakthroughs.
Conclusion
Nigel Peter Minton's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in DNA technology and cancer treatment.